Inhibiting the MAPK pathway improves heart failure with preserved ejection fraction induced by salt-sensitive hypertension-Reference-Cited by-同舟云学术

Inhibiting the MAPK pathway improves heart failure with preserved ejection fraction induced by salt-sensitive hypertension

Published:2024-01 Issue: Volume:170 Page:115987
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Li Shicheng,Shi Ying,Yuan Shanshan,Ruan Jiangwen,Pan Honglian^ORCID,Ma Mengxiao^ORCID,Huang Guoxiu,Ji Qingwei,Zhong You,Jiang Tongmeng^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference43 articles.

1. Heart disease and stroke statistics-2020 update: a report from the american heart association;Virani;Circulation,2020

2. Heart failure with preserved ejection fraction: mechanisms and treatment strategies;Omote;Annu Rev. Med,2022

3. Pharmacotherapy treatment patterns at hospital discharge and clinical outcomes among patients with heart failure with reduced ejection fraction;Wongsalap;Chronic Dis. Transl. Med.,2023

4. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure;McDonagh;Eur. Heart J.,2021

5. Heart failure with preserved ejection fraction: a review of cardiac and noncardiac pathophysiology;Gevaert;Front Physiol.,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TCM-HIN2Vec: A strategy for uncovering biological basis of heart qi deficiency pattern based on network embedding and transcriptomic experiment;Journal of Traditional Chinese Medical Sciences;2024-07

2. Microvascular rarefaction caused by the NOTCH signaling pathway is a key cause of TKI-apatinib-induced hypertension and cardiac damage;Frontiers in Pharmacology;2024-02-09